Just 7 months after the expiry of the Brexit transition period, the Medicines and Healthcare products Regulatory Agency (“MHRA”), the UK regulator overseeing medical devices (amongst other areas), has set in motion a consultative process aimed at updating the current UK legal framework relating to medical devices, which promises to “prioritise patient safety while fostering innovation”. The Medicines and Medical Devices Act 2021 (available here) empowers the MHRA to amend...
October 7, 2021
4 min read